Results 201 to 210 of about 39,021 (326)

Liquid biopsy in triple-negative breast cancer: a promising tool for diagnosis, prognosis, and treatment monitoring. [PDF]

Front Oncol
Brogna MR, Ferrara G, Varone V, Montone A, Fava A, Schiano MR, Del Sesto M, Pizza N, Prota A, Barra C, Collina F.   +10 more
europepmc   +1 more source

Outcomes of Resected Cases of Pancreatic Ductal Adenocarcinoma Patients With Unexpected Postoperative Uncovering Noncurative Factors: A Multicenter Retrospective Study

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 251-262, January 2026.
We aimed to refine treatment strategies for resected cases of pancreatic ductal adenocarcinoma in patients with unexpectedly uncovered postoperative noncurative factors. Cases with unexpected postoperative uncovering noncurative factors had significantly poorer prognoses than those without such factors.
Hiroto Matsui, Naoki Ikenaga, Masafumi Nakamura, Takaaki Tatsuguchi, Shingo Kozono, Hirohisa Okabe, Hiromitsu Hayashi, Tomohiko Adachi, Susumu Eguchi, Kazuaki Hashimoto, Toru Hisaka, Takao Ide, Hirokazu Noshiro, Teijiro Hirashita, Atsushi Miyoshi, Atsushi Nanashima, Masatoshi Kajiwara, Tomoharu Yoshizumi, Yasuhisa Mori, Hiroaki Nagano, Kyushu Study Group of Treatment for Pancreatobilliary Cancer   +20 more
wiley   +1 more source

<i>KRAS</i> Mutations in Circulating Tumor DNA for Lung Cancer Diagnosis: A Comprehensive Meta-Analysis. [PDF]

Cancers (Basel)
Buszka K, Gąsiorowski Ł, Dompe C, Szulta A, Nowicki M, Kolecka-Bednarczyk A, Budna-Tukan J.   +6 more
europepmc   +1 more source

Liquid Biopsy Innovation: ctDNA Accurately Detects Systemic Recurrence in Lung Cancer with Strong Concordance to Imaging

Michael Galo, Luis E. Raez, Jhonathan Uribe, Daniel Rosas, Xiaoqi Sun, Gelenis Domingo   +5 more
openalex   +1 more source

Significance of Serum Tumor Markers in Esophageal and Gastric Cancers: A Systematic Literature Review

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 54-66, January 2026.
The utility of serum tumor markers in esophageal squamous cell carcinoma and gastric cancer were evaluated by systematic review and meta‐analysis. In addition, the position of each marker, strategies for improving their accuracy in the future, and new markers are also described.
Yasunori Matsumoto, Takeshi Toyozumi, Hideaki Shimada   +2 more
wiley   +1 more source

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial. [PDF]

Clin Cancer Res
Browne IM, Pascual J, Cutts RJ, Kingston B, Hrebien S, Kilburn LS, Pearson A, Moretti L, Wardley AM, Macpherson IR, Baird RD, Roylance R, Gil-Gil MJ, Guerrero-Zotano ÁL, Garcia-Murillas I, Bliss JM, Ring A, Martín M, Turner NC.   +18 more
europepmc   +1 more source

Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic Implications

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Inactivating BRCA1/2 mutations confer sensitivity to poly(ADP‐ribose) polymerase inhibitors (PARPi) in prostate cancer (PCA). However, secondary BRCA1/2 reversion mutations (BRCArev) can restore BRCA function and mediate acquired PARPi resistance.
Douglas I. Lin, Elizabeth Lawrence, Natalie Danziger, Huihui Ye, Brennan Decker, Ole Gjoerup, Ryon P. Graf, Jeffrey S. Ross, Richard S. P. Huang, Julia A. Elvin, Douglas A. Mata, Rana R. McKay   +11 more
wiley   +1 more source

Added value of tumor-stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy. [PDF]

ESMO Open
Franken IA, Heilijgers F, Bakker ME, Rubio-Alarcón C, van der Baan FH, Lemmens M, Diemen PD, Sausen M, Meijer GA, Koopman M, Vink GR, Fijneman RJA, Mesker WE, Roodhart JML.   +13 more
europepmc   +1 more source

Expert opinion recommendations for external quality assessment for liquid biopsy testing from the European liquid biopsy society CTDNA workshop

Zandra C. Deans, Jennifer A. Fairley, Patrizio Giacomini, Vincent D. de Jager, Simon A. Joosse, Simon Patton, Claudia Koch, Ed Schuuring, R.D.A. Toledo, Ellen Heitzer   +9 more
openalex   +1 more source

The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT Metastatic melanoma is the most lethal form of skin cancer, accounting for most skin cancer‐related deaths. Immunotherapies and targeted therapies have improved overall and progression‐free survival rates in metastatic melanoma patients. The effectiveness of these therapies decreases due to multidrug resistance (MDR).
Jacqueline Maphutha, Danielle Twilley, Mona Dawood, Thomas Efferth, Namrita Lall   +4 more
wiley   +1 more source